Fabbrica Italiana Lapis ed Affini (FILA) H1 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2024 earnings summary
2 Feb, 2026Executive summary
H1 2024 saw strong profitability and cash flow improvements, with a sharp rise in the value of the 30.6% stake in DOMS Industries following its IPO and deconsolidation.
Core business sales declined 5.2% year-over-year (3.5% on a comparable FX basis), mainly due to DOMS deconsolidation and adverse currency effects, but Q2 showed significant recovery after Q1 disruption in North America.
Adjusted profit attributable to owners rose 35.1% to €32.0M, with improved organic margins despite lower sales.
Net debt reduced by nearly €100M year-over-year, aided by DOMS IPO proceeds and organic cash flow, though seasonality and dividends led to a temporary increase in net financial debt at period-end.
The group continues to focus on operational efficiency, cost-cutting, and working capital management.
Financial highlights
Adjusted Group Net Profit (ex-DOMS) rose to €32.0M in H1 2024 from €19.8M in H1 2023, a 61.6% increase.
Adjusted EBITDA margin improved to 21.3% in H1 2024 from 19.1% in H1 2023.
Free cash flow to equity improved to -€40.3M in H1 2024 from -€48.2M in H1 2023, reflecting seasonal working capital absorption.
Net Bank Debt at €309.6M in H1 2024, down from €408.3M in H1 2023.
Revenue fell by €82.3M year-over-year, with organic revenue down 3.5% after adjusting for DOMS and FX.
Outlook and guidance
Full-year 2024 guidance reaffirmed: stable revenue, single-digit adjusted EBITDA growth, and free cash flow to equity in the €40–50M range.
Margin improvement is anticipated due to cost optimization and reduced financial expense.
Macroeconomic uncertainty remains due to elections in key markets and global geopolitical risks.
Capital Markets Day scheduled for November 12, 2024, to provide further strategic updates.
Latest events from Fabbrica Italiana Lapis ed Affini
- Q3 2024 delivered higher EBITDA and profit, lower leverage, and confirmed guidance.FILA
Q3 20243 Feb 2026 - Profitability and cash flow surged in 2024, with strong deleveraging and robust 2025 outlook.FILA
Q4 202427 Dec 2025 - H1 2025 saw lower revenue and profit but stable margins and improved debt position.FILA
Q2 202523 Nov 2025 - Revenue and EBITDA rose, but net income dropped on FX losses; outlook remains cautious.FILA
Q1 202520 Nov 2025 - Revenue and profit fell amid macro headwinds, but debt improved and recovery is expected.FILA
Q3 202514 Nov 2025